Cite
MLA Citation
Brahim K. Bookhart et al.. “Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program.” Journal of medical economics, vol. 17, 2014, pp. 691–695. http://access.bl.uk/ark:/81055/vdc_100024950777.0x000002